[1. Lozano, R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.10.1016/S0140-6736(12)61728-0]Search in Google Scholar
[2. Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, Chatziantoniou C. Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One. 2009;21:e6721.10.1371/journal.pone.0006721]Search in Google Scholar
[3. Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents. Hypertension. 2013;61:901-7.10.1161/HYPERTENSIONAHA.111.00639]Search in Google Scholar
[4. Chatziantoniou C, Dussaule JC. Is kidney injury a reversible process? CurrOpinNephrolHypertens. 2008;17:76-81.]Search in Google Scholar
[5. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med. 2009;361:40-51.10.1056/NEJMoa0808400]Search in Google Scholar
[6. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev. 2001;103:183-8.10.1016/S0925-4773(01)00356-2]Search in Google Scholar
[7. Norris RA, Kern CB, Wessels A, et al. Identification and detection of the periostin gene in cardiac development. AnatRec A Discov Mol CellEvolBiol. 2004;281:1227-33.10.1002/ar.a.2013515532025]Search in Google Scholar
[8. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088-98.10.1056/NEJMoa110646921812663]Search in Google Scholar
[9. Naik PK, Bozyk PD, Bentley JK, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012;303:L1046-56.10.1152/ajplung.00139.2012353258323043074]Search in Google Scholar
[10. Guerrot D, Dussaule JC, Mael-Ainin M, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7:e3197410.1371/journal.pone.0031974329387422403621]Search in Google Scholar
[11. Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756-67.10.1016/j.ajpath.2011.06.002318139221854746]Search in Google Scholar
[12. Mael-Ainin M, Abed A, Conway S, Dussaule JC, Chatziantoniou C. Inhibition of Periostin expression protects against the development of renal inflammation and fibrosis. J Am SocNephrol. 2014;25:1724-36.10.1681/ASN.2013060664411605624578131]Search in Google Scholar
[13. Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant.2012;27:2702-11.10.1093/ndt/gfr670347154922167593]Search in Google Scholar
[14. Li L, Fan D, Wang C, et al. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. CardiovascRes. 2011;91:80-89.10.1093/cvr/cvr06721367774]Search in Google Scholar
[15. Uchida M, Shiraishi H, Ohta S, et al. Periostin, a matricellularprotein, plays a role in the induction of chemokines in pulmonaryfibrosis. Am J RespirCell Mol Biol. 2012;46:677-86.10.1165/rcmb.2011-0115OC430436722246863]Search in Google Scholar
[16. Curat C.A. and Vogel W.F., Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol. 2002;13:2648-2656.10.1097/01.ASN.0000032419.13208.0C12397034]Search in Google Scholar
[17. Flamant M, Placier S, Rodenas A, et al. Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. J Am Soc Nephrol. 2006;17:3374-81.10.1681/ASN.200606067717093065]Search in Google Scholar
[18. Kerroch M, Guerrot D, Vandermeersch S, et al. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. Faseb J. 2012;26:4079-91.10.1096/fj.11-19490222751008]Search in Google Scholar
[19. Guerrot D, Kerroch M, Placier S, et al. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol. 2011;179:83-91.10.1016/j.ajpath.2011.03.023312384321640971]Search in Google Scholar
[20. Gross O, Girgert R, Beirowski B, et al. Loss of collagen-receptor DDR1 delaysrenalfibrosis in hereditary type IV collagendisease. Matrix Biol.2010;29:346-56.10.1016/j.matbio.2010.03.00220307660]Search in Google Scholar
[21. Avivi-Green C, Singal M, Vogel WF. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am J RespirCrit Care Med. 2006;174:420-27.10.1164/rccm.200603-333OC16690978]Search in Google Scholar